Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2009 1
2010 2
2011 3
2012 4
2013 5
2014 6
2015 6
2016 7
2017 8
2018 11
2019 11
2020 7
2021 17
2022 13
2023 6
2024 15
2025 8
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean eugene lim (49 results)?
The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
Haggstrom L, Middleton K, Parker A, Segara D, Ong A, Bingham J, Carson EK, Kiely BE, Sabanathan D, Spillane A, Saw K, Serrano A, Lindeman GJ, Swarbrick A, Coates A, Mann GB, Tilley W, Lim E. Haggstrom L, et al. Among authors: lim e. NPJ Breast Cancer. 2026 Jul 21. doi: 10.1038/s41523-026-01008-w. Online ahead of print. NPJ Breast Cancer. 2026. PMID: 42477003 Free article.
Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer.
Chen J, Zhang H, Ruan T, Wu SZ, Slapetova I, Millar E, Graham PH, Lynch J, Browne LH, Lim E, Swarbrick A. Chen J, et al. Among authors: lim e. Cancer Res Commun. 2026 Jul 1;6(7):1605-1618. doi: 10.1158/2767-9764.CRC-25-0709. Cancer Res Commun. 2026. PMID: 42284597 Free PMC article.
SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.
Bidard FC, Barrios C, Bianchini G, Brufsky AM, Chia S, Cortes J, Cristofanilli M, Curigliano G, Dawood S, Fasching PA, Gerratana L, Giordano A, Ignatiadis M, Iwata H, Janni W, Lim E, Kalinsky K, Ma CX, Mayer EL, Medford AJ, Mouabbi JA, O'Shaughnessy J, Park YH, Pascual J, Razavi P, Sammons S, Sandoval JL, Sisca L, Tarantino P, Wander SA, Werutsky G, Turner NA. Bidard FC, et al. Among authors: lim e. NPJ Breast Cancer. 2026 Jun 8;12(1):80. doi: 10.1038/s41523-026-00967-4. NPJ Breast Cancer. 2026. PMID: 42259831 Free PMC article. No abstract available.
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling.
Fernandez KJ, Sultani G, Nobis M, Gloss B, Eshraghi L, McCart Reed AE, Alexandrou S, Lee C, Roden DL, Jones EI, Simad MH, Millar EKA, Bartonicek N, Oakes SR, Valdes-Mora F, Colino-Sanguino Y, Mok ETY, Williams HL, Kutasovic JR, Cummings MC, Stoehr J, Lee V, Harvey K, Wu S, Lakhani SR, Simpson PT, Cox TR, Ooms LM, Mitchell CA, Salomon R, Swarbrick A, Gallego-Ortega D, Lim E, Timpson P, Caldon CE. Fernandez KJ, et al. Among authors: lim e. Nat Commun. 2026 May 11;17(1):3042. doi: 10.1038/s41467-026-70683-x. Nat Commun. 2026. PMID: 42115169 Free PMC article.
Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer.
Liang J, Ong C, Heslop K, Guan J, Kameswaran V, Daniel B, Shi M, Liang Y, Giltnane JM, Aimi J, Chang CW, Gates MR, Eng-Wong J, Perez-Moreno P, Jhaveri KL, Turner NC, Lim E, Metcalfe C, Moore HM. Liang J, et al. Among authors: lim e. Nat Commun. 2026 Apr 1;17(1):4675. doi: 10.1038/s41467-026-71233-1. Nat Commun. 2026. PMID: 41917040 Free PMC article.
ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer.
Collier AE, Hilz S, Chibly AM, Duan C, Pasquina LW, Sun X, Chavez-MacGregor M, Bardia A, Martín M, Lim E, Sohn J, Pérez-Moreno PD, Fernando TM, Moore HM. Collier AE, et al. Among authors: lim e. Nat Commun. 2026 Mar 12;17(1):3848. doi: 10.1038/s41467-026-70335-0. Nat Commun. 2026. PMID: 41820395 Free PMC article. Clinical Trial.
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity.
Serrano A, Weber TS, Berthelet J, Ftouni S, El-Saafin F, Lee S, Lim E, Charafe-Jauffret E, Ginestier C, Williams D, Hollande F, Yeo B, Dawson SJ, Naik SH, Merino D. Serrano A, et al. Among authors: lim e. Mol Syst Biol. 2026 May;22(5):659-684. doi: 10.1038/s44320-026-00194-w. Epub 2026 Feb 11. Mol Syst Biol. 2026. PMID: 41673461 Free PMC article.
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
Metzger O, Mandrekar S, Goel S, Gligorov J, Lim E, Ciruelos E, Loibl S, Dockter T, Gonzàlez Farré X, Francis PA, Lynce F, Lanzillotti J, DuFrane C, Wall A, Strand C, Krop I, Vaz-Luis I, Tripathy D, Loi S, Prat A, Goetz M, Escrivá-de-Romaní S, Porter D, Spoenlein J, Stover DG, Sardesai S, Heudel P, Koehler M, Huang Bartlett C, Holynskyj A, Gopalakrishna P, Gauthier E, Delaloge S, Miller K, Winer EP, Gianni L, Partridge AH, DeMichele A, Carey LA. Metzger O, et al. Among authors: lim e. N Engl J Med. 2026 Jan 29;394(5):451-462. doi: 10.1056/NEJMoa2511218. N Engl J Med. 2026. PMID: 41604639 Clinical Trial.
135 results